Foley Hoag LLP

Foley Hoag LLP handles a broad range of mandates, advising pharmaceutical companies and academic institutions on the financing of growth stage companies and IP protection and litigation strategies. The team is also able to provide support regarding the FDA regulatory process, in addition to Medicare and Medicaid reimbursement issues. Boston’s Jeffrey Quillen took on sole leadership of the practice following Hemmie Chang‘s departure in September 2023, representing a number of emerging biotech clients as it relates to patent licensing and collaboration agreements. Universities and non-profits come to New York-based John Gourary and Rachel Beller for advice on monetizing their pharmaceutical royalties, with Boston-based Amy Baker-Mandragouras, who arrived from Cooley LLP with her team in July 2023, assisting clients on the development of the patent portfolios.